Publication | Closed Access

Dose-dependent hypolipidemic effect of an inhibitor of HMG-CoA reductase, pravastatin (CS-514), in hypercholesterolemic subjects A double blind test

Metabolic SyndromeLipid DisorderOxysterolHealth SciencesCardiovascular DiseaseMedicinePhysiologyHyperlipidemiaPharmacotherapyHypercholesterolemic SubjectsLipoprotein MetabolismMetabolismPharmacologyAtherosclerosisDyslipidemiaDose-dependent Hypolipidemic EffectDouble Blind Test